Status:

COMPLETED

PROVHILO:Protective Ventilation During General Anesthesia for Open Abdominal Surgery

Lead Sponsor:

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Collaborating Sponsors:

European Society of Anaesthesiology

Conditions:

Postoperative Respiratory Complications

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this international, multicentre, double-blinded randomized controlled trial is to determine if the "open lung approach" providing recruitment maneuvers and PEEP(Positive End Expiratory ...

Detailed Description

Research questions 1. Does mechanical ventilation with the use of higher levels of PEEP(Positive End Expiratory Pressure) and intra-operative RMs (Recruitment maneuvers) protect against pulmonary com...

Eligibility Criteria

Inclusion

  • Open abdominal surgery
  • General anesthesia
  • High or intermediate risk for postoperative pulmonary complications according to ARISCAT score \[J.Canet et al, Anesthesiology 2010;113\]

Exclusion

  • Age \> 18 years
  • Body mass index \> 40 kg/m2
  • Laparoscopic surgery
  • Previous lung surgery (any)
  • Persistent hemodynamic instability, intractable shock (considered hemodynamic unsuitable for the study by the patient's managing physician)
  • History of previous severe chronic obstructive pulmonary disease (COPD) (non-invasive ventilation and/or oxygen therapy at home, repeated systemic corticosteroid therapy for acute exacerbations of COPD)
  • Recent immunosuppressive medication (receiving chemotherapy or radiation therapy within last 2 months)
  • Severe cardiac disease (New York Heart Association class III or IV, or acute coronary syndrome, or persistent ventricular tachyarrhythmia's)
  • Mechanical ventilation \> than 30 minutes (e.g., in cases of general anesthesia because of surgery) within last 30 days
  • Pregnancy (excluded by laboratory analysis)
  • Acute lung injury or acute respiratory distress syndrome expected to require prolonged postoperative mechanical ventilation
  • Neuromuscular disease (any)
  • Consented for another interventional study or refusal to participate in the study

Key Trial Info

Start Date :

February 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 1 2013

Estimated Enrollment :

900 Patients enrolled

Trial Details

Trial ID

NCT01441791

Start Date

February 1 2011

End Date

April 1 2013

Last Update

December 9 2014

Active Locations (30)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 8 (30 locations)

1

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

2

Mayo Clinics

Rochester, New York, United States, 55905

3

Medical University,

Vienna, Austria

4

Ziekenhuis Netwerk Antwerpen

Antwerp, Belgium